Caspase-8 levels correlate with the expression of signal transducer and activator of transcription 1 in high-grade but not lower grade neuroblastoma

Cancer

Volumn 107, Issue 4, 2006, Pages 824-831

  Muscat, Andrea ^a,b   Hawkins, Christine ^a,b   Ashley, David M ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; Caspase 8; Neuroblastoma; Signal transducer and activator of transcription 1

Indexed keywords

BISULFITE; CASPASE 8; STAT1 PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER STAGING; CORRELATION ANALYSIS; DNA METHYLATION; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTRON; MALE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ASSAY; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

CASPASE 8; CASPASES; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOBLOTTING; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); STAT1 TRANSCRIPTION FACTOR;

EID: 33747181349     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22052     Document Type: Article

References (25)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203-216.
2. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288.
3. Teitz T, Wei T, Valentine MB, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. [comment]. Nat Med. 2000;6:529-535.
4. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S, Evan GI. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis.[see comment]. Science. 1997;278:1305-1309.
5. Fulda S, Lutz W, Schwab M, Debatin KM. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene. 1999;18:1479-1486.
6. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11:255-260.
7. Petak I, Houghton JA. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res. 2001;7:95-106.
8. Teitz T, Lahti JM, Kidd VJ. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J Mol Med. 2001;79:428-436.
9. Poulaki V, Mitsiades N, Romero ME, Tsokos M. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res. 2001;61:4864-4872.
10. Takita J, Yang HW, Chen YY, et al. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene. 2001;20:4424-4432.
11. Casciano I, De Ambrosis A, Croce M, et al. Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE). Cell Death Diff. 2004;11:131-134.
12. Yang X, Merchant MS, Romero ME, et al. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res. 2003;63:1122-1129.
13. Kim S, Kang J, Evers BM, Chung DH. Interferon-gamma induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter. J Pediatr Surg. 2004;39:509-515.
14. Banelli B, Casciano I, Croce M, et al. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. [comment]. Nat Med. 2002;8:1333-1335; author reply, 1335.
15. Fulda S, Debatin KM. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene. 2002;21:2295-2308.
16. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A. The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem. 2004;279:19712-19720.
17. Darnell JE Jr. STATs and gene regulation. Science. 1997;277:1630-1635.
18. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651-662.
19. Liedtke C, Groger N, Manns MP, Trautwein C. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J Biol Chem. 2003;278:27593-27604.
20. Karpf AR, Peterson PW, Rawlins JT, et al. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc Natl Acad Sci USA. 1999;96:14007-14012.
21. Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM, Stewart BW. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. Mol Cell Probes. 1993;7:227-234.
22. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111-1116.
23. Tan LW, Dobrovic A. Methylation analysis of formalin-fixed, paraffin-embedded sections using a nontoxic DNA extraction protocol. Biotechniques. 2001;31:1354,1356-1357.
24. Iolascon A, Borriello A, Giordani L, et al. Caspase 3 and 8 deficiency in human neuroblastoma. Cancer Genet Cytogenet. 2003;146:41-47.
25. Wong LH, Sim H, Chatterjee-Kishore M, et al. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J Biol Chem. 2002;277:19408-19417.